First Time Loading...

SNDL Inc
F:VY4

Watchlist Manager
SNDL Inc Logo
SNDL Inc
F:VY4
Watchlist
Price: 2.134 EUR 2.01% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

VY4 Price Targets Summary
SNDL Inc

Wall Street analysts forecast VY4 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VY4 is 3.473 EUR with a low forecast of 3.083 EUR and a high forecast of 3.945 EUR.

VY4 Lowest Forecast
Wall Street Target
3.083 EUR
44% Upside
VY4 Average Forecast
Wall Street Target
3.473 EUR
63% Upside
VY4 Highest Forecast
Wall Street Target
3.945 EUR
85% Upside
Lowest
Price Target
3.083 EUR
44% Upside
Average
Price Target
3.473 EUR
63% Upside
Highest
Price Target
3.945 EUR
85% Upside
SNDL Inc Competitors:
Price Targets
G
GLENMARK
Glenmark Pharmaceuticals Ltd
13% Downside
A
AHEALTH
Apex Healthcare Bhd
21% Downside
4151
Kyowa Kirin Co Ltd
17% Upside
V
VRNO
Verano Holdings Corp
149% Upside
G
GLENMARK
Glenmark Pharmaceuticals Ltd
13% Downside
A
AHEALTH
Apex Healthcare Bhd
21% Downside
4151
Kyowa Kirin Co Ltd
17% Upside
V
VRNO
Verano Holdings Corp
149% Upside
600479
ZhuZhou QianJin Pharmaceutical Co Ltd
32% Upside
002737
Sunflower Pharmaceutical Group Co Ltd
12% Downside
OCUL
Ocular Therapeutix Inc
155% Upside
326030
SK Biopharmaceuticals Co Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
SNDL Inc

For the last 4 years the compound annual growth rate for SNDL Inc's revenue is 94%. The projected CAGR for the next 3 years is 10%.

94%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
SNDL Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
SNDL Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

See Also

Summary
VY4 intrinsic value, competitors valuation, and company profile.
DCF Valuation
VY4 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VY4 stock valuation using valuation multiples.
Wall Street Estimates
VY4 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VY4 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VY4's stock price target?
Price Target
3.473 EUR

According to Wall Street analysts, the average 1-year price target for VY4 is 3.473 EUR with a low forecast of 3.083 EUR and a high forecast of 3.945 EUR.

What is SNDL Inc's Revenue forecast?
Projected CAGR
10%

For the last 4 years the compound annual growth rate for SNDL Inc's revenue is 94%. The projected CAGR for the next 3 years is 10%.

ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.